As the most common infection among sick patients in intensive care units, OHSU will begin its clinical trial to test if a specialized breathing tube can reduce the risk of pneumonia in emergency intubation situations.
By acquiring OHSU's MolecularMD, the clinical research organization ICON, based in Dublin, Ireland, has expanded its laboratory offering in molecular diagnostic testing and brings expanded testing platforms.
First nonhuman primate born from juvenile testicular tissue offers hope that children at risk of medically induced infertility may reproduce as adults.